This website uses cookies – including third-party cookies – for the improvement of the quality of content and adaptation it to the users' needs. By continuing to use this website, you consent to the use of cookies.
Notification on obtaining significant holding
Issuer Grindeks, AS (5299006DWR32NKWM1O86)
Document types Notifications on Holding
Language EN
Status Published
Version
Date Time 12.04.2010 10:51:46
Period
Version commentary
Text

On 12 April 2010 JSC “Grindeks” has received the notification on obtaining significant holding from OJSC “Pharmstandart”. “Pharmstandart’s” total holdings in the security of JSC “Grindeks” currently amount to 11.3 % of the outstanding shares.


“Grindeks” Chairman of the Board Janis Romanovskis: “OJSC “Pharmstandart” is the leading Russian pharmaceutical company and since 2008 is one of the most important cooperation partners of “Grindeks” that promotes and sells our brand product Mildrontate®. OJSC “Pharmstandart” as one of the biggest shareholders of “Grindeks” will strengthen our positions in Russia and provide new business opportunities.”


In the attachment: Notification from “Pharmstandart” on 4 (four) pages.

 

Further information:
Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
e-mail: laila.klavina@grindeks.lv
 

Document attachments
Farmstandart_notification.PDF (324.8 kB)